Hepatic glucose production
Biomarker1 paper1 finding
- In silico1
Interventions
1Tirzepatide
downin silico1Very low certainty
1 study
Tirzepatide
downin silico1Very low certainty
Tirzepatide decreases hepatic glucose production in silico.
In silicoversus semaglutide in type 2 diabetes28-week
Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling · The Journal of clinical endocrinology and metabolism · 20 Sep 2026
Latest
2The Journal of Clinical Endocrinology and MetabolismIn silico
Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling
ADA Scientific Sessions 2026 AbstractHuman trial
Forty Weeks of Metformin Alters Regional Insulin Sensitivity but Not Mitochondrial Function in Insulin-Resistant Adults
ADA Scientific Sessions 2025 AbstractHuman trial